Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Apr;64(4):1002-14.
doi: 10.1086/302333.

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

C E Jackson  1 , R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller, M J Lenardo, S E Straus, J M Puck
Affiliations

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

C E Jackson et al. Am J Hum Genet. 1999 Apr.

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of lymphocyte homeostasis and immunological tolerance. Most patients have a heterozygous mutation in the APT1 gene, which encodes Fas (CD95, APO-1), mediator of an apoptotic pathway crucial to lymphocyte homeostasis. Of 17 unique APT1 mutations in unrelated ALPS probands, 12 (71%) occurred in exons 7-9, which encode the intracellular portion of Fas. In vitro, activated lymphocytes from all 17 patients showed apoptotic defects when exposed to an anti-Fas agonist monoclonal antibody. Similar defects were found in a Fas-negative cell line transfected with cDNAs bearing each of the mutations. In cotransfection experiments, Fas constructs with either intra- or extracellular mutations caused dominant inhibition of apoptosis mediated by wild-type Fas. Two missense Fas variants, not restricted to patients with ALPS, were identified. Variant A(-1)T at the Fas signal-sequence cleavage site, which mediates apoptosis less well than wild-type Fas and is partially inhibitory, was present in 13% of African American alleles. Among the ALPS-associated Fas mutants, dominant inhibition of apoptosis was much more pronounced in mutants affecting the intracellular, versus extracellular, portion of the Fas receptor. Mutations causing disruption of the intracellular Fas death domain also showed a higher penetrance of ALPS phenotype features in mutation-bearing relatives. Significant ALPS-related morbidity occurred in 44% of relatives with intracellular mutations, versus 0% of relatives with extracellular mutations. Thus, the location of mutations within APT1 strongly influences the development and the severity of ALPS.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 1992 Mar 26;356(6367):314-7 - PubMed
    1. Genomics. 1992 Jun;13(2):441-3 - PubMed
    1. J Clin Invest. 1992 Aug;90(2):334-41 - PubMed
    1. Genomics. 1992 Nov;14(3):821-2 - PubMed
    1. Cell Immunol. 1993 Apr 15;148(1):91-102 - PubMed

MeSH terms